German Female Athlete Gets Back in Action, Thanks to HyProCure®

Prestigious German Orthopedic Surgeon Recognizes GraMedica®’s Innovative Sinus Tarsi Implant as the Best Solution for the Correction of Flexible Flat Feet.
By: GraMedica®
Spread the Word
Listed Under

* Hyprocure
* Gramedica
* Giii
* Foot Implant
* Foot Surgery
* Ankle Surgery
* Bunions
* Heel Pain
* Foot Pain
* Dpm
* Foot Surgeon

* Medical

* Macomb - Michigan - US

Jan. 16, 2012 - PRLog -- (MACOMB, MICHIGAN) – HyProCure®, a sinus tarsi stent made by GraMedica®, a global orthopedic medical device company, is gaining traction worldwide. In an article published in the most recent edition of Orthopädie & Rheuma (Orthopedic & Rheumatology), a German medical journal, Dr. Axel Schroth described the importance of stabilizing the talotarsal mechanism for the treatment of flexible flat feet and the benefits of HyProCure® over other treatment options.

Dr. Axel Schroth is an orthopedic surgeon specializing in foot and ankle surgery.  Dr. Schroth practices at the Orthopaedic Specialist Center Weilheim / Garmisch-Partenkirchen / Starnberg (OFZ) in Weilheim, Bavaria, Germany. He is a member of the German Orthopaedic Foot and Ankle Society (DAF) and the German Association for Foot Surgery (GFFC).

In the article, Dr. Schroth outlines his professional opinion and experiences with various treatment options for the condition that he describes as flexible flat feet. After listing the limitations and poor outcomes of many solutions, Dr. Schroth addressed the benefits and positive outcomes of Extra Osseous TaloTarsal Stabilization (EOTTS) with HyProCure®. He concluded that HyProCure®  offers significant advantages over other treatment options, such as simplified intra-operative handling and the ease of reversal. He also noted the positive clinical and radiological findings.

The article highlighted a specific case study of a 17-year-old female athlete with pain and discomfort in both feet, despite the use of orthotics and special shoes. She had previously been told she would need to have extensive hindfoot reconstructive surgery with a lengthy recovery period. Dr. Schroth instead performed EOTTS with HyProCure®  on both feet. Just 5 weeks after her HyProCure® procedure, she was swimming and diving again. At 8 weeks, the patient was alpine skiing and, merely 3 months post- surgery, she was long-distance running. This female athlete is now completely free of symptoms due to the life-changing procedure.
Dr. Schroth became qualified to perform the HyProCure® procedure back in June of 2010 after completing the online training provided by The Graham International Implant Institute (GIII), GraMedica®’s sister organization, committed to research, training, certification and support on implantology for foot physicians worldwide.  He later had the opportunity to attend a Training Seminar and Hands-on Cadaver Workshop, also made available by GIII, in Austria in June of 2011.

The condition of “flexible flat feet” is very common, affecting a large portion of the population, both children and adults. In flexible flat feet, the arch collapses when weight is put on the foot. This collapse is a secondary deformity. The true underlying deformity originates in the rear of the foot, in the ankle and heel area, due to a condition called talotarsal dislocation. It is common for patients with talotarsal dislocation to suffer from foot conditions such as general pain and inflammation, heel pain, bunions, Achilles tendonitis, and plantar fasciitis, as well as from symptoms in the rest of the body like knee pain, hip pain, back pain and even neck and shoulder complications.

GraMedica® provides a revolutionary extra-osseous talotarsal stabilization device that is placed inside the foot via a minimally invasive, out-patient procedure HyProCure® resolves the root cause of the flexible deformity and restores proper foot mechanics. As a result of anatomically correcting the foot, the alignment of the rest of the body is restored and symptoms in other parts of the body are gradually improved and often completely eliminated. HyProCure® represents a real solution for patients suffering from this condition. It has been used by foot surgeons since 2004.

Foot and ankle surgeons are invited to learn more about the HyProCure® implant and procedure at, where they can also train online and/or find a live surgical training seminar in their area.

Potential surgical candidates can find out more about the HyProCure® solution and the devastating effects of talotarsal dislocation at Find a local HyProCure® specialist through the physician locator at

Learn more about HyProCure®  and osteo-WEDGE™, GraMedica®’s latest innovative Bone Locking System at; follow updates on

About GraMedica®:
GraMedica® is a global orthopedic medical device company and leader in foot care solutions. Recognized for its innovation, the company is producer of breakthrough products like HyProCure® and osteo-WEDGE™.

Susan Doherty, Director, Education & Physician Resources

# # #

GraMedica® is a global orthopedic medical device company and leader in foot care solutions. Our products are developed to correct the root problem, not merely treat the symptoms. All products are developed by surgeons with years of experience.
Email:*** Email Verified
Tags:Hyprocure, Gramedica, Giii, Foot Implant, Foot Surgery, Ankle Surgery, Bunions, Heel Pain, Foot Pain, Dpm, Foot Surgeon
Location:Macomb - Michigan - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Graham International Implant Institute News
Most Viewed
Daily News

Like PRLog?
Click to Share